GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Allowance For Loans And Lease Losses

Oculis Holding AG (FRA:CR5) Allowance For Loans And Lease Losses


View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Allowance For Loans And Lease Losses?

Allowance For Loans And Lease Losses only applies to banks.


Oculis Holding AG (FRA:CR5) Business Description

Industry
Traded in Other Exchanges
Address
Bahnhofstrasse 7, Zug, CHE, 6300
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.